Patents by Inventor Fabrice Trovero

Fabrice Trovero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCY
    Publication number: 20160106726
    Abstract: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.
    Type: Application
    Filed: December 30, 2015
    Publication date: April 21, 2016
    Inventors: Philippe BERNARD, Fabrice TROVERO
  • Pharmaceutical composition for treating alcohol dependency
    Patent number: 9238014
    Abstract: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: January 19, 2016
    Inventors: Philippe Bernard, Fabrice Trovero
  • PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCY
    Publication number: 20120289514
    Abstract: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.
    Type: Application
    Filed: December 29, 2010
    Publication date: November 15, 2012
    Inventors: Philippe Bernard, Fabrice Trovero
  • Medicament For the Treatment of Central Nervous System Disorders
    Publication number: 20080194631
    Abstract: The invention relates to the use of a molecule, alone or in combination, chosen from the group of molecules having a simultaneous antagonist action on the alpha1-noradrenergic, glutamatergic NMDA and serotoninergic 5HT2 receptors, for the preparation of a medicament intended for treating pathologies of the central nervous system.
    Type: Application
    Filed: July 26, 2005
    Publication date: August 14, 2008
    Applicants: Key OBS, Greenpharma
    Inventors: Fabrice Trovero, Philippe Bernard